No link between Ozempic, Wegovy and suicide, EU drug regulators say
- European Union drug regulators have found no evidence that popular weight loss and diabetes drugs are linked to an increased risk of suicidal thoughts, as stated in the investigation by the European Medicines Agency.
- The investigation focused on GLP-1s, a class of drugs that suppress appetite by mimicking a gut hormone. Despite high demand and cost, these drugs have limited insurance coverage.
- The drugs Wegovy and Ozempic, among others, were the center of the investigation, which concluded with no evidence of a link to self-injury, as reported by the regulator.
Insights by Ground AI
Does this summary seem wrong?
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left7Leaning Right3Center19Last Updated18 days agoBias Distribution66% Center
Bias Distribution
- 66% of the sources are Center
66% Center
L 24%
C 66%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage